US FDA Warning Letter On LUPIN's Goa Plant | Power Breakfast | Business News | CNBC-TV18


Details of the US FDA’s warning letter on Lupin has come out. US FDA has asked Lupin to provide the corrective action plan to improve the outer specification, investigation in all facilities, updated lab investigation procedure and also performing retrospective review of the batches which have to be shipped to the US. US FDA has also pointed out the repeated observations that have taken place in Goa as well as Indore on invalidating of outer specification results. Watch the video to know the complete report.

CNBC-TV18 is India’s No.1 Business medium and the undisputed leader in business news. The channel’s benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India’s most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

Subscribe to our Channel:
Like us on Facebook:
Follow us on Twitter:



Please enter your comment!
Please enter your name here